Amylyx Pharmaceuticals, Inc. (AMLX)
13.46
-0.08
(-0.63%)
USD |
NASDAQ |
Jun 10, 16:00
13.46
0.00 (0.00%)
After-Hours: 19:51
Amylyx Pharmaceuticals Total Return Price : 13.46 for June 10, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| June 09, 2026 | 13.55 |
| June 08, 2026 | 13.01 |
| June 05, 2026 | 13.32 |
| June 04, 2026 | 14.31 |
| June 03, 2026 | 13.20 |
| June 02, 2026 | 13.29 |
| June 01, 2026 | 14.07 |
| May 29, 2026 | 14.35 |
| May 28, 2026 | 14.22 |
| May 27, 2026 | 14.07 |
| May 26, 2026 | 13.68 |
| May 22, 2026 | 13.58 |
| May 21, 2026 | 13.93 |
| May 20, 2026 | 13.61 |
| May 19, 2026 | 12.74 |
| May 18, 2026 | 12.86 |
| May 15, 2026 | 13.28 |
| May 14, 2026 | 13.88 |
| May 13, 2026 | 14.58 |
| May 12, 2026 | 14.44 |
| May 11, 2026 | 14.88 |
| May 08, 2026 | 14.73 |
| May 07, 2026 | 15.20 |
| May 06, 2026 | 16.06 |
| May 05, 2026 | 16.43 |
| Date | Value |
|---|---|
| May 04, 2026 | 16.46 |
| May 01, 2026 | 16.01 |
| April 30, 2026 | 16.00 |
| April 29, 2026 | 15.60 |
| April 28, 2026 | 16.31 |
| April 27, 2026 | 16.88 |
| April 24, 2026 | 17.04 |
| April 23, 2026 | 17.32 |
| April 22, 2026 | 17.52 |
| April 21, 2026 | 17.59 |
| April 20, 2026 | 17.57 |
| April 17, 2026 | 18.36 |
| April 16, 2026 | 17.73 |
| April 15, 2026 | 17.12 |
| April 14, 2026 | 16.92 |
| April 13, 2026 | 16.47 |
| April 10, 2026 | 16.36 |
| April 09, 2026 | 17.32 |
| April 08, 2026 | 16.92 |
| April 07, 2026 | 16.27 |
| April 06, 2026 | 15.82 |
| April 02, 2026 | 14.95 |
| April 01, 2026 | 14.35 |
| March 31, 2026 | 13.90 |
| March 30, 2026 | 12.76 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Alumis, Inc. | 20.10 |
| Merck & Co., Inc. | 119.09 |
| Ocular Therapeutix, Inc. | 8.73 |
| ANI Pharmaceuticals, Inc. | 81.76 |
| Corcept Therapeutics, Inc. | 78.16 |